ArticleFrontiers in pharmacology2026
Potential drug-drug interactions in hospitalized patients with acute coronary syndrome at a tertiary care hospital in upper Egypt.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Potential drug-drug Interactions (pDDIs) are a serious concern in cardiovascular patients and are responsible for most adverse drug reactions and drug-related hospital admissions. Clinically significant pDDIs may injure patients, create adverse outcomes, and impact healthcare costs. Therefore, pDDIs control is critical for the improvement of prescription drug safety. Aim: The present study aimed to assess potential pDDIs among cardiovascular patients at a Tertiary Care Hospital in Upper Egypt. Methods: A prospective observational study was performed on acute coronary syndrome (ACS) patients attending Assiut University Heart Hospital. The Lexi-Interact online was used to assess pDDIs. Multiple logistic regression was used to identify the factors associated with pDDIs. Results: A total of 371 patients attending Assiut University Heart Hospital were recruited for the study. A total of 2,504 pDDIs were detected among the patients. The mean number of drugs prescribed per patient was 7.78 ± 1.73. Class C, D, and X DDIs were found in 74.76%, 10.02%, and 0.04%, respectively. Aspirin and ticagrelor were the most prevalent pDDIs under category D (232, 92.4%). A combination of ramipril and aspirin was the most frequently encountered interacting pair in the class C (281, 17.2%). STEMI patients, length of hospital stay, and a higher number of prescribed drugs were significantly associated with the occurrence of pDDIs, according to multiple logistic regression. Conclusion: Patients with ACS were frequently exposed to pDDIs with the highest drug-related problems, treatment failure, and negative consequences. Therefore, clinical pharmacists ought to be more involved in managing complex drug regimens and improving therapeutic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.